Kura Oncology, Inc.

Related records

Trials (23)

• A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia
• A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
• A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
• A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
• Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies
• Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
• Expanded Access to Tipifarnib
• Expanded Access to Ziftomenib
• First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
• First-in-Human Study of KO-947 in Non-Hematological Malignancies
• Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
• Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
• Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
• TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
• Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
• Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia
• Tipifarnib in Subjects With Myelodysplastic Syndromes